NCT00232947View on ClinicalTrials.gov

Study Comparing Immune Response to, and Safety of, Fluviral and Fluzone Influenza Vaccines in Persons 50 y.o. and Over

PHASE3CompletedINTERVENTIONAL

Enrollment

900

Participants

Timeline

Start Date

October 31, 2005

Study Completion Date

February 28, 2006

Conditions

Influenza

Interventions

BIOLOGICAL

Influenza virus vaccine (Fluviral)

BIOLOGICAL

Influenza virus vaccine (Fluzone)

Trial Locations (10)

13760

Regional Clinical Research, Endwell

14642

University of Rochester Medical Center, Rochester

22030

PI-Coor Clinical Research, Fairfax

30342

Radiant Research, Atlanta

33024

University Clinical Research, Inc., Pembroke Pines

45236

Radiant Research, Cincinnati

60610

Radiant Research, Chicago

64114

The Center for Pharmaceutical Research, Kansas City

66211

Vince and Associates Clinical Research, Overland Park

02886

Omega Medical Research, Warwick

All Listed Sponsors

lead

ID Biomedical Corporation, Quebec

INDUSTRY

NCT00232947 - Study Comparing Immune Response to, and Safety of, Fluviral and Fluzone Influenza Vaccines in Persons 50 y.o. and Over | Biotech Hunter | Biotech Hunter